Case Studies

Diana M. Sobieraj, PharmD, and Craig I. Coleman, PharmD
Published Online: Monday, January 20, 2014
Follow Pharmacy_Times:
Case 1
MJ is a 44-year-old female who comes to the pharmacy to purchase a box of Oxytrol for Women. She states that she has been experiencing symptoms of urinary incontinence in which she “feels like I have to go but can’t control it,” and she feels embarrassed by the amount of times she has to go to the bathroom daily. Recently, she has had a few additional episodes of incontinence related to sneezing. She saw a commercial for Oxytrol on TV and thought she would try it before talking with her doctor. MJ denies any other significant medical history other than hypertension, which is well controlled by lisinopril 40 mg daily. She has no known allergies.
As the available pharmacist, do you believe MJ is a candidate for OTC Oxytrol for Women?

Case 2
BT is a 65-year-old male with hypertension, type 2 diabetes mellitus (DM), osteoarthritis, and benign prostatic hypertrophy. He had a myocardial infarction 2 years ago and has been taking Lipitor 80 mg daily ever since. BT has tolerated therapy very well and has no complaints of muscle aches and pains. His liver function test results have always been within normal limits. He expresses concern about the strength of his statin therapy and questions the need for such a high dose.
Is high-dose statin therapy appropriate for BT according to the new American College of Cardiology–American Heart Association guidelines for the treatment of high cholesterol?

Dr. Sobieraj is assistant professor of pharmacy practice, and Dr. Coleman is professor of pharmacy practice as well as codirector and methods-chief, at Hartford Hospital Evidence-Based Practice Center at the University of Connecticut School of Pharmacy.


Related Articles
People who performed at the highest fitness levels on a stress test were projected to have a 20 percent less chance of developing high blood pressure over five years.
Researchers are calling for updated diabetes prevention guidelines that incorporate fetal experiences into the risk equation.
Two new guidelines have many clinicians, newscasters, and patients talking.
Latest Issues
$auto_registration$